自身免疫性风湿病中的心血管磁共振:欧洲心血管影像协会临床共识文件
该共识文件由欧洲心血管影像协会制定,回顾了心血管磁共振(CMR)在自身免疫性风湿病(ARDs)患者心血管受累早期诊断中的作用,并与其它无创影像方法比较;提出基于共识的决策算法以确定何时可考虑CMR检查,同时给出标准化扫描方案,并讨论CMR检查结果的临床意义。
要点
- CMR可在同一检查中评估双心室功能并对血管/心肌进行组织特征分析,提供疾病活动度的可靠评估。
- CMR有助于在临床显性心血管疾病出现前早期识别病理生理性结构/功能改变,可能拓展治疗窗口。
- 共识提出基于共识的决策算法,用于判断ARDs患者何时可考虑行CMR检查,并给出标准化扫描方案。
核心结论
- CMR可早期识别ARDs患者临床显性心血管疾病出现前的病理生理性结构/功能改变,提供可能不被血液生物标志物和其他影像方法反映的疾病活动度评估,从而为及时临床决策和个体化治疗提供诊断信息。
研究设计与样本
- 欧洲心血管影像协会(European Association of Cardiovascular Imaging)临床共识文件,基于文献回顾与专家共识制定,提出CMR在ARDs中的应用决策算法和标准化扫描方案。
临床应用与阅片要点
- 共识提出基于共识的决策算法,用于判断ARDs患者何时可考虑行CMR检查,并给出标准化扫描方案。
- CMR可在同一次检查中评估双心室功能并对血管/心肌进行组织特征分析,用于评估疾病活动度。
- CMR可在临床显性心血管疾病出现前早期识别病理生理性结构/功能改变,为及时临床决策和个体化治疗提供信息。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Autoimmune rheumatic diseases (ARDs) involve multiple organs including the heart and vasculature. Despite novel treatments, patients with ARDs still experience a reduced life expectancy, partly caused by the higher prevalence of cardiovascular disease (CVD). This includes CV inflammation, rhythm disturbances, perfusion abnormalities (ischaemia/infarction), dysregulation of vasoreactivity, myocardial fibrosis, coagulation abnormalities, pulmonary hypertension, valvular disease, and side-effects of immunomodulatory therapy. Currently, the evaluation of CV involvement in patients with ARDs is based on the assessment of cardiac symptoms, coupled with electrocardiography, blood testing, and echocardiography. However, CVD may not become overt until late in the course of the disease, thus potentially limiting the therapeutic window for intervention. More recently, cardiovascular magnetic resonance (CMR) has allowed for the early identification of pathophysiologic structural/functional alterations that take place before the onset of clinically overt CVD. CMR allows for detailed evaluation of biventricular function together with tissue characterization of vessels/myocardium in the same examination, yielding a reliable assessment of disease activity that might not be mirrored by blood biomarkers and other imaging modalities. Therefore, CMR provides diagnostic information that enables timely clinical decision-making and facilitates the tailoring of treatment to individual patients. Here we review the role of CMR in the early and accurate diagnosis of CVD in patients with ARDs compared with other non-invasive imaging modalities. Furthermore, we present a consensus-based decision algorithm for when a CMR study could be considered in patients with ARDs, together with a standardized study protocol. Lastly, we discuss the clinical implications of findings from a CMR examination.
引用
- Mavrogeni S, Pepe A, Nijveldt R, et al. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022. PMID: 35808990. doi:10.1093/ehjci/jeac134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。